Featured Articles

BitTorrent And Oversi Collaborate To Deliver Optimal P2P Solution For ISPs In Today's Financial Downturn

BitTorrent And Oversi Collaborate To Deliver Optimal P2P Solution For ISPs In Today's Financial Downturn

Dec 09 2008 | comment(s)

SAN FRANCISCO and PETACH TIKVA, Israel, December 9 /PRNewswire/ --

- Client Protocols Work Hand-in-Hand With Network Intelligence to Save Costs and Improve Users' Internet Experience

BitTorrent, the global standard technology for the delivery of rich media on the Internet, and Oversi, a pioneer of over-the-top (OTT) caching and delivery solutions, today announced their collaboration to deliver an integrated solution that optimizes P2P traffic across the Internet Service Provider (ISP) network. In today's business climate, the joint solution brings clear benefits to ISPs: reduced bandwidth costs and deferred infrastructure investments together with a higher quality subscriber experience.

Data Shows Longest Ever Survival For Patients With Life-Threatening Leukaemia Treated With Breakthrough Treatment

Data Shows Longest Ever Survival For Patients With Life-Threatening Leukaemia Treated With Breakthrough Treatment

Dec 08 2008 | comment(s)

FRIMLEY, England, December 8 /PRNewswire/ --

- 86 Percent of Patients With Ph+ Chronic Myeloid Leukaemia Treated With Breakthrough Treatment Glivec(R) are Alive After Seven Years(1)

- Treatment Shown to Slow Disease Progression: Only one Patient out of 317 Experienced Disease Progression Between Year Six and Seven of Treatment(1)

- Data Demonstrate Longest Overall Survival Observed to Date in This Disease Area

Dassault Aviation Signs Memorandum Of Understanding With INCAT And Tata Technologies

Dassault Aviation Signs Memorandum Of Understanding With INCAT And Tata Technologies

Dec 08 2008 | comment(s)

LONDON, PUNE, India and DETROIT, December 8 /PRNewswire/ --

- Agreement underscores INCAT's expertise in the aerospace market and its commitment to leveraging this capability in India

Dassault Aviation and INCAT's parent company, Tata Technologies, have signed a Memorandum of Understanding (MoU) for ESO services. Under the terms of the MoU, INCAT, a global leader in Engineering Services Outsourcing (ESO), will provide Dassault Aviation with Engineering Services in a number of critical domains, in support of the Indian Air Force MMRCA program, which involves significant offset requirements.

INCAT has been selected as a key offset partner for ESO delivery to help fulfill these offset requirements.

Optical Lattice Stores Quantum Information For A 7-Millisecond Eternity

Optical Lattice Stores Quantum Information For A 7-Millisecond Eternity

Dec 08 2008 | comment(s)

It may seem, at least to those of us who have been alive long enough to witness any of the advances in semiconductor technology, that computer power has been improving at breakneck speed. A quantum computer, however - a theoretical type of computer that utilizes the states of atoms to store information instead of magnetic fields - may make our current conception of computing power completely obsolete. And now, new research into the storage and retrieval of quantum information has brought quantum computing one step closer to reality.
Will This HIV Vaccine Succeed Where Others Have Failed?

Will This HIV Vaccine Succeed Where Others Have Failed?

Dec 08 2008 | comment(s)

Since the 80’s, as the awareness of HIV has increased exponentially, scientists have struggled for a vaccine to quell the rising number of AIDS-related deaths occurring each year. According to an AIDS epidemic update released in December of 2006  by the Joint United Nations Program on HIV/AIDS (UNIADS) and the World Health Organization (WHO), there were 39.5 million people worldwide living with HIV. That includes the 4.3 million newly infected individuals that year alone, and not including the 2.9 million deaths from AIDS in 2006.

Emailvision Officially Creates Its Swiss Subsidiary In Geneva

Emailvision Officially Creates Its Swiss Subsidiary In Geneva

Dec 08 2008 | comment(s)

GENEVA, December 8 /PRNewswire/ -- Emailvision, the first European market and technology leader in on-demand software for e-mail marketing automation, is pleased to announce the official creation of its swiss subsidiary in Geneva.

Emailvision has organized a client cocktail on Thursday December 11th at 5pm at FloorTwo (lounge bar of Kempinski Hotel) with Nick Heys - CEO Founder, Guy Porre - CCO General Manager and Herve Bloch -Managing Director Emailvision Switzerland.

From his nomination to Country Manager Position in April 2008, Herve Bloch recruited sales and production teams for Geneva as well as for our Zurich office. Those teams will manage Switzerland operations and also East European Russian activities.

LYCOS Webhosting Recommends STRATO As Provider For Its Customers / Transition Of Domains

LYCOS Webhosting Recommends STRATO As Provider For Its Customers / Transition Of Domains

Dec 08 2008 | comment(s)

GÜTERSLOH, Germany, December 8 /PRNewswire/ -- LYCOS Europe introduces STRATO a strong European Webhosting provider, as its exclusive partner for LYCOS Webhosting customers who based on the current situation would like to re-orientate themselves.

STRATO and LYCOS are currently focusing on the transferring of domains which will guarantee in making the transition as easy as possible.

In addition STRATO are offering free of charge a Hotline, Online-Chat and Call-back service for any queries that might arise.

More information relating this partnership will be released mid December. The LYCOS Webhosting branch will still be operating during the first quarter of 2009.

Agendia Supports High Profile CME Symposium And Presents Compelling Data At The 2008 San Antonio Breast Cancer Symposium

Agendia Supports High Profile CME Symposium And Presents Compelling Data At The 2008 San Antonio Breast Cancer Symposium

Dec 08 2008 | comment(s)

HUNTINGTON BEACH, California and AMSTERDAM, December 8 /PRNewswire/ -- Agendia, a world leader in molecular cancer diagnostics, today announced that leading Agendia and the Netherlands Cancer Institute researchers will present data from multiple studies at the 2008 San Antonio Breast Cancer Symposium (SABCS) and Agendia will support, with an unrestricted grant, the New Frontiers in Individualized Breast Cancer Therapy symposium. The San Antonio Breast Cancer Symposium, one of the premiere conferences in breast cancer research worldwide, takes place December 10th-14th, 2008.

A Brave New World, Re-revisited

A Brave New World, Re-revisited

Dec 08 2008 | comment(s)

I was astounded to read the news about scientists essentially promoting pills to improve brain function - surely I had read the article wrong, I thought. But no.
DeCODE To Integrate New Genetic Risk Factor For Type 2 Diabetes Into Its DeCODEme(TM) Personal Genome Scan Service

DeCODE To Integrate New Genetic Risk Factor For Type 2 Diabetes Into Its DeCODEme(TM) Personal Genome Scan Service

Dec 08 2008 | comment(s)

REYKJAVIK, Iceland, December 8 /PRNewswire/ --

deCODE genetics (Nasdaq: DCGN) today announced the discovery by an international consortium of scientists from deCODE and major European and US academic institutions of a single letter variation in the human genome (SNP) that is associated with increased fasting glucose levels and risk of type 2 diabetes (T2D). deCODE will employ its CLIA-registered genotyping laboratory and existing testing platform to swiftly integrate the finding into its deCODEme(TM) personal genome scan, and to assess the addition of this new variant to the company's deCODE T2(TM) reference laboratory test for assessing individual risk of type 2 diabetes.

Non-Invasive Glucose Monitoring - Solianis Monitoring AG

Non-Invasive Glucose Monitoring - Solianis Monitoring AG

Dec 08 2008 | comment(s)

ZURICH, Switzerland, December 8 /PRNewswire/ --

- Breakthrough Home Use Study Finalised

- Board of Directors Reinforced

Solianis has just finalised a test series in which patients with diabetes have worn the first configuration of the multisensor system for non-invasive Continuous Glucose Monitoring at home and at work. Results show that the system tracks glucose in these settings and that it is sensitive to hyper- and hypoglycemic glucose excursions.

Channel Says Supermicro Their Best Partner In X86 Server Solutions

Channel Says Supermicro Their Best Partner In X86 Server Solutions

Dec 08 2008 | comment(s)

SAN JOSE, California, December 8 /PRNewswire/ --

Super Micro Computer, Inc. (Nasdaq: SMCI), a leader in application-optimized, high performance server solutions, today announced that the channel has ranked Supermicro as the number one x86 server vendor over HP, IBM, Dell, Sun, Apple and Gateway. As published in the November 24th issue of CRN (Channel Reseller News), the 2008 Channel Affinity Index, which is based on the result of 8,000 survey responses conducted with solutions providers, ranks Supermicro as the top x86 server vendor.

(Photo: http://www.newscom.com/cgi-bin/prnh/20081208/AQM062)

Beyond Seizure Control In The Treatment Of Epilepsy With New Anti-Epileptic Drug, Zebinix(TM)

Beyond Seizure Control In The Treatment Of Epilepsy With New Anti-Epileptic Drug, Zebinix(TM)

Dec 08 2008 | comment(s)

PORTO, Portugal, December 8 /PRNewswire/ --

- Data Highlight The Efficacy, Safety and Significant Improvement in Quality of Life and Depressive Symptoms With Zebinix(TM) (Eslicarbazepine Acetate)

Positive data from three phase III studies presented today at the American Epilepsy Society (AES) Congress, Seattle, USA, show that Zebinix(TM)(1) (eslicarbazepine acetate), a novel once-daily anti-epileptic agent, significantly reduced the frequency of partial seizures and has the potential to significantly improve quality of life and depressive symptoms in patients with partial refractory epilepsy, in combination with other anti-epileptic agents.(2),(3),(4)

Zebinix(TM) is one of the proposed EU trade names for eslicarbazepine acetate.

Kiadis Pharma Receives Two Orphan Drug Designations For Reviroc(TM) From The FDA

Kiadis Pharma Receives Two Orphan Drug Designations For Reviroc(TM) From The FDA

Dec 08 2008 | comment(s)

AMSTERDAM, December 8 /PRNewswire/ -- Biopharmaceutical company Kiadis Pharma announces today that the U.S. Food and Drug Administration (FDA) has granted its product Reviroc(TM) Orphan Drug Designations (ODD) for the treatment of two types of Non-Hodgkin Lymphoma (NHL). One ODD has been granted for diffuse large B-cell lymphoma and the other one for the treatment of follicular lymphoma. Reviroc(TM) is under development for the elimination of cancer cells from an autologous graft in bone marrow transplantations for end-stage blood cancer patients.

This is an important strategic milestone in the development of Reviroc(TM) and we are very pleased with the orphan drug designations received from the FDA, says Dr. Manja Bouman, Chief Executive Officer of Kiadis Pharma.

The Atlantic Hotel Implements MICROS OPERA

The Atlantic Hotel Implements MICROS OPERA

Dec 08 2008 | comment(s)

LONDON, December 8 /PRNewswire/ --

- First Small Luxury Hotels of the World property in Europe to install two-way interface to SLH's Central Reservation System

MICROS-Fidelio UK Ltd, a wholly-owned subsidiary of MICROS Systems, Inc. (Nasdaq: MCRS), a leading provider of information technology solutions for the hospitality and retail industries, is pleased to announce that The Atlantic Hotel is the first Small Luxury Hotels of the World (SLH) property in Europe to deploy MICROS's OPERA Xpress Property Management System (PMS).

Honeywell's Low-Global-Warming-Potential Refrigerant Endorsed By SAE International Cooperative Research Project

Honeywell's Low-Global-Warming-Potential Refrigerant Endorsed By SAE International Cooperative Research Project

Dec 08 2008 | comment(s)

MORRIS TOWNSHIP, New Jersey, December 8 /PRNewswire/ --

- SAE's International Cooperative Research Program finds new refrigerant offers 'superior environmental performance'

Honeywell (NYSE: HON) announced today that the SAE International Cooperative Research Program has endorsed Honeywell's low-global-warming-potential refrigerant for use in mobile air conditioning (MAC) to meet new, more stringent regulations in Europe.

The SAE program team said refrigerant HFO-1234yf offers superior environmental performance and that this alternative refrigerant -- of all proposed alternatives -- has been judged to have the lowest risk for use in mobile air conditioning systems in meeting environmental and consumer needs.

Calling fellow bloggers

Calling fellow bloggers

Dec 08 2008 | comment(s)

Calling fellow bio bloggers -- help get the word out for the special issue of Evolution: Education and Outreach
all about eye evolution. The content is free to access online and the
authors include many of the world's top eye evolution researchers. A
handy table of contents with links is provided below for easy copy and
paste maneuvers.

Evolution: Education and Outreach
Volume 1 Issue 4

Editorial

Autotask Leads The PSA Industry In Successful Technology Integrations

Autotask Leads The PSA Industry In Successful Technology Integrations

Dec 08 2008 | comment(s)

EAST GREENBUSH, New York, December 8 /PRNewswire/ --

- Company's open API and 'Ready for Autotask' program proven to integrate seamlessly with the business applications and managed services platforms Autotask customers rely on most

Autotask Corporation today announced it is leading the PSA industry in successful technology integrations and using its open API and Ready for Autotask program to actively engage IT-focused vendors and manufacturers and simplify the integration and interoperability process.

Autotask CEO Bob Godgart says it is these technology alliances that really differentiate and strengthen the company's central role within the IT services ecosystem and help its customers to grow their services business faster and more effectively.

Review Of Pay And Finance Will Not End The Upstairs-Downstairs Culture In Higher Education, Says Unite

Review Of Pay And Finance Will Not End The Upstairs-Downstairs Culture In Higher Education, Says Unite

Dec 08 2008 | comment(s)

LONDON, December 8 /PRNewswire/ -- Unite, UK's largest union, with the largest number of occupational groups in higher education, is calling for universities to end the two-tier system of pay and benefits between academic and support staff.

Responding to today's (Monday) publication of the UK Universities Higher Education Finance and Pay Data Review, Unite is urging that efforts to address the difference of terms and conditions between academic and support staff are stepped and an end brought to the upstairs, downstairs treatment of staff within higher education which has seen staff in some occupational groups earning salaries close to minimum wage levels.

BioWa Licenses POTELLIGENT(R) Technology To GlaxoSmithKline For Use In Antibody Development And Commercialization

BioWa Licenses POTELLIGENT(R) Technology To GlaxoSmithKline For Use In Antibody Development And Commercialization

Dec 08 2008 | comment(s)

PRINCETON, New Jersey, December 8 /PRNewswire/ --

BioWa, Inc., announced today that it licensed to GlaxoSmithKline (NYSE: GSK) its POTELLIGENT(R) Technology for use in developing and commercializing select GSK antibodies with enhancement of antibody-dependent cellular cytotoxicity (ADCC).

GSK is recognized as a key player in the field of antibody drug discovery, said Dr. Masamichi Koike, BioWa President and CEO. We believe this represents an important opportunity to promote the development of more effective targeted treatments for debilitating diseases where enhanced ADCC might offer a significant therapeutic benefit.